D.E. Shaw & Co’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-14,146
Closed -$214K 4563
2025
Q2
$214K Hold
14,146
﹤0.01% 4033
2025
Q1
$204K Hold
14,146
﹤0.01% 3926
2024
Q4
$214K Sell
14,146
-4,092
-22% -$65.8K ﹤0.01% 4054
2024
Q3
$300K Sell
18,238
-9,660
-35% -$158K ﹤0.01% 3975
2024
Q2
$458K Sell
27,898
-121,457
-81% -$1.95M ﹤0.01% 3673
2024
Q1
$2.49M Sell
149,355
-253,676
-63% -$3.93M ﹤0.01% 2457
2023
Q4
$6.03M Hold
403,031
0.01% 1761
2023
Q3
$5.84M Sell
403,031
-7,629
-2% -$114K 0.01% 1687
2023
Q2
$6.26M Buy
+410,660
New +$6.17M 0.01% 1698

Other funds holding BCAT

D.E. Shaw & Co's BCAT Position: Q3 2025 in Review

D.E. Shaw & Co sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q3 2025, closing a stake of 14,146 shares — an estimated $214K sold.

D.E. Shaw & Co first reported a position in BCAT in Q2 2023 and held it in 9 quarters. The position peaked at $6.26M in Q2 2023. 94 funds tracked by Wall St. Rank hold BCAT as of Q3 2025.

  • D.E. Shaw & Co reported no remaining BlackRock Capital Allocation Term Trust position as of Q3 2025 after selling out during the quarter.
  • D.E. Shaw & Co sold 14,146 BlackRock Capital Allocation Term Trust shares in Q3 2025, an estimated $214K.
  • D.E. Shaw & Co first reported a position in BlackRock Capital Allocation Term Trust in Q2 2023 and held it in 9 quarters.
  • D.E. Shaw & Co's BlackRock Capital Allocation Term Trust position peaked at $6.26M in Q2 2023.
  • 94 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q3 2025.

Based on D.E. Shaw & Co's 13F filing for Q3 2025, filed 14 Nov 2025.